626. Deputy Ken O'Flynn asked the Minister for Health whether repeated breaches of ambulance allocation KPIs at local, regional, or national level trigger any formal escalation mechanism to senior HSE management, the HSE Board, or the Department of Health. [41177/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
760 questions match, newest first.
627. Deputy Ken O'Flynn asked the Minister for Health whether any adverse clinical outcome review, morbidity review, mortality review, or patient harm assessment process examines whether delayed ambulance allocation formed a contributory factor in patient outcomes. [41178/26]
628. Deputy Ken O'Flynn asked the Minister for Health whether the National Ambulance Service maintains any internal threshold defining what constitutes an extreme or critical ambulance allocation delay for governance or patient-safety purposes. [41179/26]
629. Deputy Ken O'Flynn asked the Minister for Health whether ambulance allocation delays are monitored by individual call duration bands including delays exceeding 5 minutes, 10 minutes, 20 minutes, 30 minutes, or longer. [41180/26]
630. Deputy Ken O'Flynn asked the Minister for Health whether any internal reports, dashboards, governance papers, board reports, risk reports, or performance reviews since 2020 have identified ambulance allocation delays as a patient-safety concern. [41181/26]
631. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any analysis correlating ambulance allocation delays with staffing shortages, ambulance availability, emergency department overcrowding, or hospital offload delays. [41182/26]
632. Deputy Ken O'Flynn asked the Minister for Health whether any external body other than IAED or PHECC has independently reviewed National Ambulance Service dispatch performance, governance, or KPI compliance since 2020. [41183/26]
633. Deputy Ken O'Flynn asked the Minister for Health whether the National Ambulance Service records the longest ambulance allocation delay experienced for PURPLE and RED calls each year. [41184/26]
634. Deputy Ken O'Flynn asked the Minister for Health whether the HSE considers compliance with ambulance allocation KPIs to constitute a patient-safety issue, an operational performance issue, or both. [41185/26]
635. Deputy Ken O'Flynn asked the Minister for Health to provide the full list of data fields recorded within any centralised HSE database, case-management system, spreadsheet, or reporting structure used for the administration of the Treatment Abroad Scheme. [41201/26]
636. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme records procedure categories using standardised coding systems; if so, to specify those systems. [41202/26]
637. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme records the clinical indication or diagnosis associated with approved treatments abroad. [41203/26]
638. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme records destination hospital, provider, and jurisdiction for each approved case. [41204/26]
639. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme records estimated approved cost and final reimbursed expenditure separately for each approved case. [41205/26]
640. Deputy Ken O'Flynn asked the Minister for Health the number of internal audits, external audits, Comptroller and Auditor General reviews, or governance reviews concerning the treatment abroad scheme have taken place since 2020, broken down by year. [41206/26]
641. Deputy Ken O'Flynn asked the Minister for Health whether any audit, review, or oversight process relating to the treatment abroad scheme identified deficiencies in data collection, reporting, expenditure monitoring, or governance controls since 2020. [41207/26]
642. Deputy Ken O'Flynn asked the Minister for Health whether minutes, reports, briefing documents, dashboards, or expenditure summaries arising from quarterly treatment abroad scheme oversight meetings with the Department of Health Eligibility Unit are retained centrally. [41208/26]
643. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme maintains outcome-monitoring data regarding procedures funded abroad, including complication rates, revision procedures, adverse events, or follow-up care requirements. [41209/26]
644. Deputy Ken O'Flynn asked the Minister for Health whether the HSE intends to establish a formal national reporting framework for the treatment abroad scheme including standardised activity, expenditure, and governance reporting. [41210/26]
645. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General audit of the treatment abroad scheme conducted in 2022 identified any governance, procedural, administrative, documentation, authorisation, oversight, compliance, or record-keeping observations, recommendations, or weaknesses, notwithstanding the statement that there were no findings regarding expenditure. [41211/26]
646. Deputy Ken O'Flynn asked the Minister for Health whether the 2022 Comptroller and Auditor General audit of the treatment abroad scheme examined specific procedure categories or referral pathways and, if so, to provide details of the categories examined. [41212/26]
647. Deputy Ken O'Flynn asked the Minister for Health whether the 2022 audit of the treatment abroad scheme included examination of prior authorisation processes, consistency of decision-making, regional variations, documentation standards, consultant referral verification, MDT governance procedures, and post-treatment outcome monitoring. [41213/26]
648. Deputy Ken O'Flynn asked the Minister for Health whether any internal HSE audit, compliance review, governance review, risk assessment, or assurance exercise relating to the treatment abroad scheme has been conducted since the 2022 Comptroller and Auditor General audit. [41214/26]
649. Deputy Ken O'Flynn asked the Minister for Health whether any recommendations, observations, action points, or governance improvements arose from the 2022 audit of the treatment abroad scheme; and, if so, whether all such actions have been implemented. [41215/26]
650. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a formal audit trail for all treatment abroad scheme approvals, including consultant recommendations, MDT documentation, authorisation decisions, expenditure approvals, and post-treatment verification documentation. [41216/26]